675 related articles for article (PubMed ID: 7505386)
1. [Prevalence of HBV surface antigens, anti-HBD and anti-HCV antibodies in patients with virus-related chronic liver disease].
Ozyilkan E; Tatar G; Köseoğlu T; Ozkuyumcu C; Kayhan B; Telatar H
Mikrobiyol Bul; 1993 Oct; 27(4):308-13. PubMed ID: 7505386
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and presentation of hepatitis C related chronic liver disease in southern India.
Issar SK; Ramakrishna BS; Ramakrishna B; Christopher S; Samuel BU; John TJ
J Trop Med Hyg; 1995 Jun; 98(3):161-5. PubMed ID: 7783272
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of HBsAg, anti-HCV and anti-HDV positivity in diverse groups].
Doğanay M; Patiroğlu T; Utaş C; Ozbakir O; Unal A; Utaş S; Aygen B; Yücesoy M
Mikrobiyol Bul; 1993 Apr; 27(2):107-12. PubMed ID: 7684812
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Inoue J; Ulaankhuu D; Okamoto H
Arch Virol; 2005 Dec; 150(12):2513-28. PubMed ID: 16012782
[TBL] [Abstract][Full Text] [Related]
6. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
[TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology of hepatitis B, C, D and E viruses among children in Moscow, Russia.
Abe K; Hayakawa E; Sminov AV; Rossina AL; Ding X; Huy TT; Sata T; Uchaikin VF
J Clin Virol; 2004 May; 30(1):57-61. PubMed ID: 15072755
[TBL] [Abstract][Full Text] [Related]
8. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers.
Liaw YF; Tsai SL; Sheen IS; Chao M; Yeh CT; Hsieh SY; Chu CM
Am J Gastroenterol; 1998 Mar; 93(3):354-9. PubMed ID: 9517639
[TBL] [Abstract][Full Text] [Related]
9. Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia.
Tsatsralt-Od B; Takahashi M; Endo K; Buyankhuu O; Baatarkhuu O; Nishizawa T; Okamoto H
J Med Virol; 2006 May; 78(5):542-50. PubMed ID: 16555292
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
Resnick RH; Koff R
Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and outcomes of HBV and anti-HCV seropositive patients with chronic liver disease and hepatocellular carcinoma.
Pramoolsinsap C; Sumalnop K; Busagorn N; Kurathong S
Southeast Asian J Trop Med Public Health; 1992 Mar; 23(1):6-11. PubMed ID: 1326124
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia.
Inoue J; Takahashi M; Nishizawa T; Narantuya L; Sakuma M; Kagawa Y; Shimosegawa T; Okamoto H
J Med Virol; 2005 Jul; 76(3):333-40. PubMed ID: 15902700
[TBL] [Abstract][Full Text] [Related]
13. [Studies on HDV and HCV infection in plasma donors with positive HBsAg].
Wang SP; Ding H; Zhao OK
Zhonghua Yu Fang Yi Xue Za Zhi; 1994 Jul; 28(4):223-4. PubMed ID: 7531135
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
Gessoni G; Manoni F
Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
[TBL] [Abstract][Full Text] [Related]
15. [Incidence of hepatitis B, C and D infection in chronic liver diseases].
Horváth G; Tolvaj G; Dávid K
Orv Hetil; 1992 Sep; 133(39):2475-80. PubMed ID: 1408083
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B, C and Delta virus infections in Albanian patients with chronic liver disease: evaluation of possible changes during the last 10 years.
Kondili LA; Cuko L; Chionne P; Candido A; Madonna E; Dentico P; Resuli B; Taliani G; Brunetto MR; Rapicetta M
Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):167-71. PubMed ID: 19734797
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).
Diop-Ndiaye H; Touré-Kane C; Etard JF; Lô G; Diaw P; Ngom-Gueye NF; Gueye PM; Ba-Fall K; Ndiaye I; Sow PS; Delaporte E; Mboup S
J Med Virol; 2008 Aug; 80(8):1332-6. PubMed ID: 18551596
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of antibodies to hepatitis C virus among Saudi patients with chronic liver diseases.
Ayoola EA; al-Mofleh IA; al-Faleh FZ; al-Rashed R; Arif MA; Ramia S; Mayet I
Hepatogastroenterology; 1992 Aug; 39(4):337-9. PubMed ID: 1385286
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.
Khan A; Kurbanov F; Tanaka Y; Elkady A; Sugiyama M; Dustov A; Mizokami M
J Med Virol; 2008 Feb; 80(2):268-76. PubMed ID: 18098133
[TBL] [Abstract][Full Text] [Related]
20. [The role of the hepatitis B, C and D viruses in the etiology of chronic hepatopathies in Cluj].
Neamţu A; Pascu O; Szanto P; Chira O; Neamţu D; State D
Bacteriol Virusol Parazitol Epidemiol; 1995; 40(2):119-23. PubMed ID: 7549253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
